- Home
- CELU vs SWIN Comparison
CELU vs SWIN Comparison
Compare CELU & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- SWIN
- Stock Information
- Founded
- CELU 2016
- SWIN 2017
- Country
- CELU United States
- SWIN Hong Kong
- Employees
- CELU N/A
- SWIN N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- SWIN
- Sector
- CELU Health Care
- SWIN
- Exchange
- CELU Nasdaq
- SWIN Nasdaq
- Market Cap
- CELU 37.7M
- SWIN 32.1M
- IPO Year
- CELU N/A
- SWIN 2023
- Fundamental
- Price
- CELU $2.11
- SWIN $1.71
- Analyst Decision
- CELU
- SWIN
- Analyst Count
- CELU 0
- SWIN 0
- Target Price
- CELU N/A
- SWIN N/A
- AVG Volume (30 Days)
- CELU 91.2K
- SWIN 193.7K
- Earning Date
- CELU 05-08-2025
- SWIN 06-10-2025
- Dividend Yield
- CELU N/A
- SWIN N/A
- EPS Growth
- CELU N/A
- SWIN N/A
- EPS
- CELU N/A
- SWIN N/A
- Revenue
- CELU $54,220,000.00
- SWIN $2,419,000.00
- Revenue This Year
- CELU $23.29
- SWIN N/A
- Revenue Next Year
- CELU N/A
- SWIN $61.68
- P/E Ratio
- CELU N/A
- SWIN N/A
- Revenue Growth
- CELU 138.11
- SWIN N/A
- 52 Week Low
- CELU $1.00
- SWIN $1.16
- 52 Week High
- CELU $5.22
- SWIN $5.33
- Technical
- Relative Strength Index (RSI)
- CELU 54.10
- SWIN 50.70
- Support Level
- CELU $1.90
- SWIN $1.43
- Resistance Level
- CELU $2.47
- SWIN $1.78
- Average True Range (ATR)
- CELU 0.29
- SWIN 0.18
- MACD
- CELU 0.01
- SWIN -0.03
- Stochastic Oscillator
- CELU 58.25
- SWIN 59.68
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.